LACTATE DEHYDROGENASE INHIBITOR AND ANTIEPILEPTIC DRUG CONTAINING SAME

EPO Patent Application EP 3257/510 A1
Application Date: Dec. 20th, 2017

ABSTRACT

The invention provides a lactate dehydrogenase inhibitor that makes it possible to suppress refractory epilepsy in which conventional antiepileptic drugs are ineffective, and an antiepileptic drug containing said inhibitor. The...
Assignee(s):
Inventor(s):
INOUE, Tsuyoshi
SADA, Nagisa
Application Number:
16749227.1
International Classification:
A61K 31/36 (20060101); A61P 25/08 (20060101); A61P 43/00 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

A lactate dehydrogenase inhibitor containing a compound represented by formula (III): wherein Ra represents a hydrogen atom, a halogen atom or alkoxy optionally substituted with halogen atoms;Rb represents a hydrogen atom, a halogen atom, alkoxy optionally substituted with halogen atoms or nitro, or represents a group which together with Rc, Rd or...

DESCRIPTION

TECHNICAL FIELD

The present invention relates to a lactate dehydrogenase inhibitor and an antiepileptic drug containing isosafrole (or a derivative thereof) as an active ingredient.
Back to Top